HyperLink

Home      About     Contact Us    Make this your homepage   
Conferences
Recruitment NEW
Training Courses
Market Tutorials
Market Reports
Custom Analysis
Audio CDs
Past Conferences

Purchase CD >>

Social & Ethical Aspects of Stem Cell Research
Sarah Franklin, Professor of Social Studies of Biomedicine, London School of Economics

Getting Value Out of Stem Cell and Regenerative Technologies
Julian Hitchcock, Senior Solicitor, Mills & Reeve

Short, Medium and Long-Term Opportunities for Stem Cell Research
Hugh Ilyine, Vice President and Chief Operating Officer, Stem Cell Sciences

Moving Stem Cells from the Laboratory of Specialists, to the Bench of Generalists
Fergus McKenzie, Stem Cell Technologies Programme Manager, ITI Life Sciences

Stem Cells: The International Bio-Ethical Landscape
Stephen Minger, Director, Stem Cell Biology Laboratory, King's College

Risk Governance and Regulation of Stem Cells as Therapeutic Products
James Mittra, Research Fellow, ESRC Innogen Centre, University of Edinburgh

Criteria for Venture Capital Investment
Cathy Prescott, Director, Biolatris

Issues Facing a Spin Out Stem Cell Company
Stefan Przyborski, Director and Chief Scientific Officer, ReInnervate

Market Trends in the Stem Cells Space
Enal Razvi, Industry Analyst

Sources of Funding for Stem Cell Research
Ben Sykes, Senior Programme Manager, UK National Stem Cell Network

From Stem Cell Research to Therapy
Ian Wilmut, Director, Centre for Regenerative Medicine, University of Edinburgh

ALSO ON THIS CD

Spotlight Presentations from Stem Cell Companies
20 minute talks on the technology and business prospects of existing, emerging and potential spin-out companies

  • Cellartis
    Johan Hyllner, CSO
  • Nikon
    Simon Denham, Biological Imaging Systems Specialist
  • amaxa
    Gerhard Muster, Product Manager
  • Crionna
    Lynne Douglas, Managing Director
  • Guava Technologies
    Lars Ohl, European Applications Manager

    • Panel Discussions

    Challenges to Market Entry – IP, Legal, Manufacturing
    Moderator: Marilyn Robertson, Director, Scottish Stem Cell Network

    Panellists:
  • Marc Turner, Scientific Director, Scottish National Blood Transfusion Service
  • Nick Bassil, Partner, Kilburn & Strode
  • Sarah Franklin, Professor of Social Studies of Biomedicine, L.S.E.

    • Lessons from Monoclonal Antibodies and GM Crops; Fast Track to Market and Public Acceptance Moderator: Fergus McKenzie

    Panellists:
  • Joyce Tait, Director, ESRC Innogen Centre
  • Hugh Ilyine, Vice President and COO, Stem Cell Sciences
  • James Reid, CEO, Haptogen
  • Johan Hyllner, CSO, Cellartis
  • Stefan Przyborski, Director and CSO, ReInnervate

    •  
    © SelectBiosciences 2007